Late thrombolytic therapy improves thallium uptake in acute myocardial infarctions a report from the second MT. Sinai-Nyu reperfusion trial  by Feit, Frederick et al.
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: Late thr ic t&es for acute MI results 
in improved Thallium uptake, independent of MI location. 
This finding suggests that the observed mortality 
reduction results at least in part from salvage of 
qocardium. 
